General Information of DT
DT ID DTD0251
Gene Name SLC2A1
Protein Name Glucose transporter type 1, erythrocyte/brain
Gene ID
6513
UniProt ID
P11166
TCDB ID
2.A.1.1.28
3D Structure

Crystal Structure

Crystallisation Method: X-ray

PDB ID: 5EQG

Corresponding Chain: A

Sequence Length: 1-492

Detail: Struture Info

Synonyms CSE; DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; HepG2 glucose transporter; PED; SDCHCN; SLC2A1; Solute carrier family 2, facilitated glucose transporter member 1
DT Family Major Facilitator Superfamily (MFS)
Sugar Porter (SP) Family
Tissue Specificity Detected in erythrocytes (at protein level).Expressed at variable levels in many human tissues.
Function This transporter has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses. Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake.
Endogenous Substrate(s) Dehydroascorbate; Arsenite; D-glucose
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT

(β) Post-translational Modification of This DT

(γ) Transcriptional Regulation of This DT

(δ) Epigenetic Regulation of This DT

(ε) Exogenous Modulation of This DT

Structural Variability Data of This DT (VARIDT 2.0)

(α) Mutation-induced Structural Variation

(β) Inter-species Structural Differences

(γ) Outward/inward-facing Conformation

(δ) Xenobiotics-regulated Structural Variability

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT

(β) Disease-specific Protein Abundances of This DT

(γ) Species- and Tissue-specific DT Abundances

Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
D-glucose
Approved Drug Info Hypoglycemia 5A21; 5A41 [1]

 Clinical Trial Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
2-Deoxyglucose
Phase 1/2 Drug Info Cancer 2A00-2F9Z [3]

 Phase 3 Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Quercetin
Phase 3 Drug Info Coronary artery disease BA6Z [2]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
3-hydroxybutyrate
3541112
EM Info Unclear experiment used for identifying this EM [4]

Drug-DT Affinity Assessed by Cell Line

 Withdrawn, Discontinued or Preclinical Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Dehydroascorbic acid Investigative Drug Info Chinese hamster ovary (CHO) cells-GLUT1 Km = 1100 microM [5]
References
1 The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38.
2 Oral Bioavailability and Disposition of Phytochemicals
3 Glutamine 161 of Glut1 glucose transporter is critical for transport activity and exofacial ligand binding. J Biol Chem. 1994 Aug 12;269(32):20533-8.
4 Epigenetic regulation of the glucose transporter gene Slc2a1 by beta-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice. Genes Cells. 2017 Jan;22(1):71-83.
5 Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997 Jul 25;272(30):18982-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.